NVR LCI (Tekturna HCT 150 mg-12.5 mg)
Generic Name: aliskiren/hydrochlorothiazide
Pill with imprint NVR LCI is White, Elliptical / Oval and has been identified as Tekturna HCT 150 mg-12.5 mg. It is supplied by Novartis Pharmaceuticals.
Tekturna HCT is used in the treatment of high blood pressure and belongs to the drug class miscellaneous antihypertensive combinations. There is positive evidence of human fetal risk during pregnancy. Tekturna HCT 150 mg-12.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for NVR LCI
Tekturna HCT
- Generic Name:
- aliskiren/hydrochlorothiazide
- Imprint:
- NVR LCI
- Strength:
- 150 mg-12.5 mg
- Color:
- White
- Size:
- 15.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antihypertensive combinations
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Novartis Pharmaceuticals
- Inactive Ingredients:
-
- silicon dioxide
- crospovidone
- hypromelloses
- ferric oxide red
- lactose
- magnesium stearate
- microcrystalline cellulose
- polyethylene glycol
- povidone
- magnesium silicate
- titanium dioxide
- wheat starch
Note: Inactive ingredients may vary.
Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 00078-0521 | Novartis Pharmaceuticals Corporation |
| 54868-6041 | Physicians Total Care Inc. (repackager) |
More about Tekturna HCT (aliskiren / hydrochlorothiazide)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 4 Reviews
- Drug class: miscellaneous antihypertensive combinations
- FDA Alerts (1)
- FDA Approval History
Consumer resources
Professional resources
Other Formulations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
